Original Title: 12-month results of a novel large access closure device: insights from the FRONTIER II Study. Presenter: Arne Schwindt   The FRONTIER II trial assessed the safety and efficacy of the vessel closure device VIVASURE in more than 50 patients using the femoral access for TAVI or aortic endoprosthesis. Puncture site was assessed at…